Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_assertion description "[Thus, OBP-401 in combination with docetaxel efficiently enhances the antitumor efficacy both in vitro and in vivo, and the outcome has important implications for tumor-specific oncolytic chemovirotherapies for human cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_assertion evidence source_evidence_literature NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_assertion SIO_000772 16477640 NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_assertion wasDerivedFrom befree-20140225 NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_assertion wasGeneratedBy ECO_0000203 NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP588974.RAv4RKMx8j9DgdtmJ4YTcuQ5ts2leHPPGjYxH2jKk-ItI130_provenance.